Neogenomics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
My name is Casey Woodring. I'm a member of the life sciences tools and diagnostics research team at JPMorgan. Today, It's my pleasure to introduce the management team from NeoGenomics. (Operator Instructions)
And with that, let me turn it over to Doug. Doug?
Okay. Thank you, Casey, and thanks for inviting us to the conference this year. We're really pleased to be able to share the NeoGenomics story. And we think it's a story that's getting better and better, and we have enormous potential for the future.
Now for those of you looking at the presentation, I think we can bring up the slide deck. Let's turn to Slide 3, and we'll give you a quick sense for who we are. We're a comprehensive oncology diagnostics company, and we really exist because cancer patients need help with precision therapies. And we're in the business of precision medicine, and that's what we do. Our emphasis and our employees are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |